Migraine monoclonal antibodies against CGRP change brain activity depending on ligand or receptor target - an fMRI study.
Hauke BasedauLisa-Marie SturmJan MehnertKuan-Po PengMarlene SchellongArne MayPublished in: eLife (2022)
The basic science study was preregistered in the Open Science Framework (https://osf.io/m2rc6).
Keyphrases